newsfilter
← Latest News
Business Wire·

CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology

Keynote presentation at leading head and neck cancer conference will include new findings from CEL-SCI’s landmark Phase 3 study, the largest in the world for its indication CEL-SCI’s patient selection method is a